Sunday March 21, 2010 7:04 AM ET
-
Bank Notes | College Planning | Debt | Elder Care | Employment | Estate Planning | Health Care | Insurance | Marriage & Divorce | Real Estate | Retirement | Taxes
-
Share Price ($):
38.45Price Change:
-0.26 (-0.67%)
Last 10 Quotes
What is this?
SNY
(SANOFI-AVENTIS ADS)
Exchange: NYSE
Industry: Drug Manufacturers/Major
Last Trade 4:03 PM ET 3/19/2010
 |
| Volume: | 1,686,997 |
|---|---|
| Day's Low: | $38.00 |
| 52-wk Low: | $25.57 |
| Previous Close: | $38.71 |
| Dividend: | $1.63 |
| Market Cap: | 101,391,000 |
| Avg Volume: | 1,498,600 |
|---|---|
| Day's High: | $38.57 |
| 52-wk High: | $41.59 |
| Open Price: | $38.37 |
| Yield: | 4.24% |
| P/E (Forward): | NA |
Breaking News
| 4:52 PM | 3/19/2010 | UPDATE: Teva Sees $9.2 Billion Europe Revenue By 2015 Without Deals |
| 7:51 AM | 3/17/2010 | UPDATE: WHO Suspends Use, Purchase Of Sanofi Unit's Shan5 |
| 6:23 AM | 3/17/2010 | WHO Suspends Use, Purchase Of Sanofi Unit's Shan5 Vaccine |
| 6:34 PM | 3/16/2010 | UPDATE:Sen Kohl Probes Price Differences In Drugs In US, Abroad |
| 5:37 PM | 3/16/2010 | Sen Kohl Probes Price Differences In Drugs Sold In US, Abroad |
| 12:56 PM | 3/16/2010 | Emerging Markets To Make Half Of Pharma Sales Growth By '13 -Study |
| 10:43 AM | 3/15/2010 | Study Casts Doubt On Long-Term Plavix Use After Stents |
Stories & Blogs: Around the Web
| 3/18/2010 | It's better to have lusted and lost than to have overpaid and won. (The Motley Fool) |
| 3/18/2010 | Teva Beats Pfizer to Ratiopharm (Barrons.com) |
| 3/18/2010 | FDA Is Easing Way for Drug Cocktails (WSJ.com) |
| 3/17/2010 | Flea, Tick Products Come Under Scrutiny (WSJ.com) |
| 3/17/2010 | Novartis gets some bad clinical-trial news. (The Motley Fool) |
| 3/17/2010 | WHO Suspends Sanofi Vaccine (WSJ.com) |
| 3/16/2010 | Hype your company and then get the wrong answer from the FDA. (The Motley Fool) |
| 3/16/2010 | AstraZeneca Maps 'Selective' Expansion in Emerging Markets (WSJ.com) |
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | NA | NA | NA |
| EPS, GAAP | -0.84 | -0.83 | -1.20 |
| Consensus Estimate | NA | NA | NA |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | NA | NA | NA |
| EPS, GAAP | 1.21 | 1.03 | 17.48 |
| Consensus Estimate | NA | NA | NA |
| SNY | Industry Average | |
| P/E (TTM) | 31.78 | 13.10 |
| P/E (Forward) | NA | NA |
| PEG Ratio | NA | NA |
| Price/Sales | 3.17 | 2.64 |
| Beta | 0.84 | 0.86 |
Advertisements
Hear our feeds on Jott
Post/View comments about this company
SmartMoney Mobile | Customer Service | Magazine Customer Service | Subscribe to SmartMoney Magazine | Your Profile | Contact Us
Reprints | About Our Ads | Corrections | Custom Publishing | License Our Content | Media Kit | Press Room | Events | Site Map | Labs |
Reprints | About Our Ads | Corrections | Custom Publishing | License Our Content | Media Kit | Press Room | Events | Site Map | Labs |
You Are Viewing: SmartMoney.com — Investing, Saving and Personal Finance.
